| Item number | Description |
|---|---|
| 48135 | Nautilus™ Smart ECMO module |
| 48160 | Nautilus™ oxygenator holder |
| 48150 | Nautilus™ smart power supply |
| 48155 | Nautilus™ smart power cord |
ECMO products
Nautilus™ Smart ECMO oxygenator module
<p>The Nautilus™ Smart ECMO oxygenator module combines the function of an oxygenator with integrated monitors that display real-time device performance data.</p>
Features
Simplification. Monitoring. Alerts in real time.
Performance predictability
View monitored parameters on the interactive touch screen.
- Pressure in, pressure out, ΔP
- O2 saturation in, O2 saturation out
- Temperature out
- Set alarm limits
- Receive visual and audio alert notifications
Circuit simplicity
- Integrated sensors may eliminate the need for pressure transducers and external blood saturation monitoring.2–4
- Simplify the circuit for patient transport, ambulation, and rehabilitation.2–4
- Fewer connections minimize the number of areas prone to blood clot formation and air entrainment.2–4
Streamlined workflow
- Light bar provides at-a-glance assessment of oxygenator performance
- Reduces need to look at multiple devices to get oxygenator-related performance data
- Visual and audio alerts when limits are exceeded
- Displayed data allows clinicians to clearly communicate oxygenator status among ECMO team members
Designed for ECMO
Circular flow-path technology
The Nautilus™ Smart ECMO module has a transverse flow-path with a circular profile. Transverse flow minimizes surface contact area while achieving a low blood-side pressure drop. The circular profile eliminates corners where low flow and stasis are known to occur. Designed for durability and long-term performance, the circular flow-path design improves long-term gas transfer.1
Circular shape
Eliminates corners, areas known for clotting
Guided inlet‡
Reduces velocity changes at the inlet where low flow and stasis may occur
Filling vanes
Aid in even filling and even flow distribution across the membrane
Performance data
Designed for durability and long-term performance1
Blood path pressure drop
Oxygen transfer
Heat exchange performance factor
Carbon dioxide transfer
Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.
Ordering information
Related links
Similar products
-
Crescent™ RA jugular dual-lumen catheterThe Crescent™ RA catheter is a right atrial-designed dual lumen catheter available in sizes 13, 15, and 19 Fr.
-
Crescent™ jugular dual-lumen catheterThe Crescent™ catheter is a bicaval-designed dual lumen catheter available in sizes 24, 26, 28, 30, and 32 Fr. Used for long-term ECMO.
-
Nautilus™ ECMO oxygenator with Balance™ biosurfaceThe Nautilus™ ECMO oxygenator with Balance™ biosurface, featuring a circular flow-path design, is ready to be incorporated into an ECMO circuit.
-
VitalFlow™ ECMO systemThe VitalFlow™ ECMO system provides control of blood pumping through an extracorporeal circuit during extracorporeal membrane oxygenation (ECMO) procedures.
† Indicated in the United States for use up to 48 hours.
‡ Patent pending.
- Design verification and validation data on file at MC3. These tests may not be indicative of clinical performance.
- Haneya A, Philipp A, Foltan M, Camboni D, Müeller T, Bein T, et al. First experience with the new portable extracorporeal membrane oxygenation system Cardiohelp for severe respiratory failure in adults. Perfusion. 2012 Mar;27(2):150–5. doi: 10.1177/0267659111432330.
- Alwardt CM, Wilson DS, Alore ML, et al. Performance and safety of an integrated portable extracorporeal life support system for adults. J Extra Corpor Technol. 2015;47(1):38–43.
- Lequier L, Horton SB, McMullan DM, Bartlett RH. Extracorporeal membrane oxygenation circuitry. Pediatr Crit Care Med. 2013;14(5 Suppl 1):S7–12. doi: 10.1097/PCC.0b013e318292dd10.